Abnormal lymphocytes on a blood test usually fall into one of two broad categories: reactive cells responding to an infection or other immune trigger, and neoplastic cells tied to a blood cancer or precancerous condition. The distinction matters enormously for what happens next, but it can be surprisingly hard to make from a blood smear alone. Most people who see “abnormal lymphocytes” or “atypical lymphocytes” flagged on a lab report are dealing with something temporary and benign, though the finding always warrants a closer look.
What “Abnormal” Actually Means on a Lab Report
Normal lymphocytes under the microscope are small, round cells with a thin rim of cytoplasm. When a lab technician or automated analyzer flags lymphocytes as abnormal, it means the cells look different from that baseline in some way: they might be larger than usual, have more cytoplasm, contain irregular nuclei, or show other structural changes. The catch is that both harmless reactive lymphocytes and dangerous malignant cells can look unusual, and laboratory specialists do not always agree on which category a given cell falls into. A study examining how consistently lab professionals classified variant lymphocytes found that the distinction between reactive and malignant types is crucial for patient care but can be difficult based on appearance alone.1Europe PMC / Journal of Clinical Pathology. The divergent morphological classification of variant lymphocytes in blood smears
This is why a flag for abnormal lymphocytes on a routine blood count is a starting point, not a diagnosis. It tells your doctor something unusual is happening with your immune cells and that further investigation is needed to figure out whether the cause is an infection, a drug reaction, physical stress, or something that needs more urgent attention.
Infections Are the Most Common Trigger
Viral infections are, by a wide margin, the most frequent reason lymphocytes look abnormal. When your body encounters a virus, certain lymphocytes activate, enlarge, and start dividing rapidly to fight off the invader. These activated cells look different enough under a microscope that they get flagged as “reactive” or “atypical.” The cells are doing exactly what they are supposed to do; they just happen to look unusual while doing it.
Epstein-Barr virus, the cause of infectious mononucleosis, is the classic example. EBV-driven atypical lymphocytosis tends to produce large numbers of activated CD8-positive T cells and natural killer cells, and the atypical lymphocyte counts tend to be higher than in cases triggered by other viruses.2PubMed. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis In some cases of mono, the virus temporarily infects CD8-positive cells themselves and triggers clonal proliferation of those infected cells, which can look alarming on lab tests but typically resolves on its own.3PubMed. Infectious mononucleosis accompanied by clonal proliferation of EBV-infected cells and infection of CD8-positive cells
EBV is far from the only culprit. Cytomegalovirus, hepatitis viruses, HIV, and respiratory viruses can all cause reactive lymphocytes to show up on a blood smear. During the COVID-19 pandemic, researchers noted that a substantial majority of hospitalized patients showed reactive lymphocytes on their blood films. Other infections like dengue, toxoplasmosis, and even some bacterial infections can trigger similar changes. The common thread is that the immune system is mounting an aggressive response, and the lymphocytes reflect that effort.
Medications and Severe Drug Reactions
Certain medications can provoke abnormal lymphocyte responses, and the most dramatic version of this is a condition called DRESS syndrome (drug reaction with eosinophilia and systemic symptoms). DRESS is a severe, potentially life-threatening drug reaction in which T lymphocytes become massively activated, producing a flood of inflammatory signals that can damage the skin, liver, kidneys, and other organs. The condition involves a combination of genetic susceptibility related to specific immune system genes, problems in how the body metabolizes the offending drug, and reactivation of herpes viruses (especially HHV-6) that amplifies the immune response.4World Allergy Organization Journal. DRESS syndrome: A literature review and treatment algorithm
Aromatic anticonvulsants like phenytoin, carbamazepine, and lamotrigine are among the most common triggers, but antibiotics (particularly sulfonamides), allopurinol, and several other drug classes can also cause it. In DRESS, the abnormal lymphocytes on the blood smear are part of a broader picture that includes rash, fever, swollen lymph nodes, and organ involvement. If you develop a widespread rash with fever and abnormal blood counts a few weeks after starting a new medication, that combination should prompt urgent medical evaluation.
Stress Lymphocytosis
An underappreciated cause of temporarily abnormal lymphocyte counts is acute physical stress. In emergencies like major trauma, cardiac events, seizures, anaphylaxis, or sickle cell crises, the body can dump lymphocytes into the bloodstream rapidly, producing a transient spike that looks striking on a blood count.5PubMed Central. Transient Stress Lymphocytosis in a Child: A Case Report and Systematic Review of the Literature This stress lymphocytosis is typically short-lived, resolving within hours to days once the triggering event passes. It can be confusing when it shows up on an emergency room blood draw, because the elevated or unusual-looking lymphocytes may initially raise concern for infection or malignancy before the clinical picture clarifies.
The mechanism is different from what happens during infection. Rather than lymphocytes activating and expanding in response to a pathogen, stress lymphocytosis involves the rapid mobilization of lymphocytes that were already present in tissues like the spleen and lymph nodes, pushed into the bloodstream by surges of adrenaline and cortisol. If you had blood drawn during or shortly after a medical emergency and saw abnormal lymphocyte results, this is one possible explanation your doctor will consider.
When the Cause Is More Serious
The reason doctors take abnormal lymphocytes seriously is that they can also be an early sign of blood cancers. Chronic lymphocytic leukemia is the most common of these, and it often first shows up as an incidental finding on routine bloodwork: the lymphocyte count is elevated, and the cells may look slightly different from normal. Other lymphoid malignancies, including various non-Hodgkin lymphomas, can occasionally enter a “leukemic phase” where abnormal lymphoma cells spill into the bloodstream and appear on peripheral blood smears.6PubMed. Non-Hodgkin’s lymphomas in leukemic phase: clinicopathologic correlations Diffuse large B-cell lymphoma, typically an aggressive lymphoma found in lymph nodes, can occasionally present this way, with abnormal blast-like cells appearing in peripheral blood alongside low platelet counts.7PubMed Central. Diffuse large B-cell lymphoma presenting in the leukemic phase
Acute lymphoblastic leukemia is another possibility, particularly in children, where immature lymphocytes called lymphoblasts flood the bloodstream. These cells have distinctive features on laboratory testing, including altered enzyme activity compared to normal lymphocytes.8Blood. Lymphoblast purine pathway enzymes in B-cell acute lymphoblastic leukemia They also express surface receptors in patterns that differ from normal cells, which helps pathologists identify them.9Blood. Characterization of lymphoblast Fc receptor expression in acute lymphoblastic leukemia
A study of patients with persistent lymphocytosis (meaning the elevated counts stuck around) found that among those referred for further workup, roughly 72% turned out to have a malignant cause and about 28% were benign.10Journal of Renal Endocrinology. Evaluation of the frequency of benign reactive lymphocytosis and lymphoproliferative disorders by flow cytometry in patients with persistent lymphocytosis in peripheral blood That sounds alarming, but keep in mind that this was a selected group: patients whose abnormal counts persisted long enough and looked concerning enough to warrant specialized testing. The vast majority of people who get a single flag for atypical lymphocytes on routine bloodwork have a reactive, self-limiting cause. Male sex and older age were both associated with higher likelihood of malignancy in that study.
The Gray Zone of Monoclonal B-Cell Lymphocytosis
Between clearly benign reactive lymphocytes and overt leukemia sits a condition that can create a lot of anxiety: monoclonal B-cell lymphocytosis, or MBL. In MBL, a small population of identical (clonal) B cells circulates in the blood, but the count stays below the threshold used to diagnose CLL. The dividing line between MBL and CLL is essentially a cell count cutoff, and some researchers have questioned whether MBL is truly a separate entity or just an early stage of the same disease.11Blood. Monoclonal B-Cell Lymphocytosis (MBL) Is Closely Related to Chronic Lymphocytic Leukemia (CLL) and May Be Better Classified as Early-Stage CLL
The practical question for anyone diagnosed with MBL is whether it will progress to something requiring treatment. The answer depends heavily on how many clonal cells are present. A large screening study of over 10,000 individuals found that people with high-count MBL had a dramatically elevated risk of progressing to a lymphoid malignancy, while those with low-count MBL had a much more modest increase in risk compared to people without the condition at all.12PubMed Central. Progression and survival of MBL: a screening study of 10 139 individuals For low-count MBL, the lifetime risk of ever needing treatment for leukemia remains small enough that most hematologists recommend periodic monitoring rather than intervention. High-count MBL, on the other hand, is watched more closely, with regular blood counts to track whether the clonal population is growing.
MBL is worth knowing about because it sometimes gets discovered incidentally during workup for abnormal lymphocytes, and the diagnosis can feel frightening even when the immediate risk is low. If you are told you have MBL, the most important question to ask your hematologist is whether it falls into the low-count or high-count category, because the implications for follow-up are quite different.
How Doctors Figure Out the Cause
The diagnostic process for abnormal lymphocytes typically moves through several stages, and understanding this sequence can make the experience less stressful if you are the patient being worked up.
The first step is usually a peripheral blood smear, where a lab technician examines your blood cells under a microscope. This gives a rough sense of whether the abnormal cells look reactive (suggesting infection or inflammation) or suspicious for malignancy (suggesting further testing). Modern automated hematology analyzers can also flag certain populations; for instance, some instruments detect cells with high fluorescence, which correlates with the presence of specific abnormal cell types in the blood with reasonable accuracy.13PubMed. Sensitivity and specificity of the high fluorescent lymphocyte count-gate on the Sysmex XE-5000 hematology analyzer for detection of peripheral plasma cells
If the blood smear raises questions, the next step is often flow cytometry, a technique that identifies exactly which types of immune cells are present and whether they are clonal (all identical, suggesting malignancy) or polyclonal (diverse, suggesting a normal immune response). Flow cytometry is particularly important for detecting MBL and CLL, where the cells may not look dramatically abnormal under the microscope but carry telltale surface markers.
When flow cytometry or the clinical picture suggests a possible malignancy, genetic testing of the abnormal cells may follow. Techniques like FISH (fluorescence in situ hybridization) and conventional karyotyping can reveal chromosomal abnormalities that help classify the disease and guide treatment decisions. Combining these approaches improves diagnostic accuracy and can uncover evolving clonal populations that a single test might miss.14PubMed. FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia
Bone marrow biopsy is not always necessary but comes into play when the peripheral blood findings are inconclusive or point toward a diagnosis that requires tissue confirmation. Research has shown that when a careful blood smear review leads to a bone marrow biopsy, the biopsy almost always yields a specific diagnosis, which speaks to the value of that initial microscopic assessment in guiding the workup.15PubMed Central. Peripheral Smear Review and Bone Marrow Biopsy Correlation In cases where the peripheral smear is truly inconclusive, bone marrow aspirate tends to be the most helpful next step for reaching a definitive answer.16International Journal of Medical and Biomedical Studies. TO STUDY BONE MARROW ASPIRATE AND BONE MARROW BIOPSY IN THOSE HEMATOLOGIC DISORDERS IN WHICH THE PERIPHERAL BLOOD SMEAR EXAMINATION RESULTS ARE INCONCLUSIVE.
What the Timeline Looks Like
If the abnormal lymphocytes stem from an acute infection, you can generally expect the blood picture to normalize within a month or two after the infection clears. Mono can be on the longer end of that range, sometimes leaving atypical lymphocytes circulating for several weeks after symptoms improve. Stress lymphocytosis, as mentioned earlier, resolves much faster, typically within hours to a couple of days.
The timeline becomes a diagnostic clue in itself. When abnormal lymphocytes persist beyond a couple of months without an obvious infectious or drug-related explanation, that is when doctors become more concerned about an underlying lymphoproliferative disorder and move toward flow cytometry or other advanced testing. A lymphocyte count that stays elevated or continues to climb over serial blood draws is a different clinical picture from one that is already trending back toward normal.
For people diagnosed with MBL or early-stage CLL, the monitoring timeline stretches much longer. Many patients with low-count MBL are followed with blood counts every six to twelve months, and a significant number never require any treatment at all. The waiting and watching can feel unnerving, but for slow-growing conditions, premature treatment does not improve outcomes and can carry its own risks.
Abnormal Lymphocytes in Children
Children deserve their own discussion because the context and common causes of atypical lymphocytes differ from adults in important ways. Children normally have higher lymphocyte counts than adults, so the threshold for what counts as elevated is age-dependent. A lymphocyte count that would be flagged in a 50-year-old might be perfectly normal in a toddler.
When children do show atypical lymphocytes, the assumption often jumps to mono, but this may be wrong more often than parents expect. A study of children with at least 5% atypical lymphocytes found that none of them had acute infectious mononucleosis. The children tested were mostly seronegative for EBV, and among those with EBV antibodies, the patterns indicated past infection rather than an active case.17PubMed Central. Atypical lymphocytosis in children Other viruses, including adenovirus, respiratory syncytial virus, and enterovirus, are common triggers for atypical lymphocytes in younger children who may not yet have encountered EBV.
Acute lymphoblastic leukemia, while rare overall, is the most common childhood cancer, and it does present with abnormal lymphocytes (specifically lymphoblasts) in the blood. Pediatricians are trained to look for accompanying features like persistent fatigue, bruising, bone pain, and low red cell or platelet counts that would distinguish leukemia from a viral response. An isolated finding of some atypical lymphocytes in an otherwise well child with a recent cold is a very different scenario from a child with unexplained weight loss and pancytopenia.
Autoimmune Conditions and Chronic Inflammation
Beyond infections, drugs, and malignancies, chronic autoimmune and inflammatory conditions can produce abnormal-looking lymphocytes or persistent lymphocytosis. In disorders like rheumatoid arthritis, systemic lupus, and inflammatory bowel disease, the immune system is chronically activated, and the ongoing stimulation of lymphocytes can lead to elevated counts or morphological changes visible on a blood smear. These tend to be modest compared to what a viral infection or malignancy produces, but they can complicate interpretation when a patient with known autoimmune disease gets routine bloodwork and sees an unexpected flag.
Post-transplant patients on immunosuppressive drugs face a unique situation. Their medications dampen the immune system to prevent rejection, but this suppression sometimes allows latent viruses (particularly EBV and cytomegalovirus) to reactivate, producing atypical lymphocytes that can mimic a lymphoproliferative disorder. Transplant teams monitor for this carefully because a subset of post-transplant lymphoproliferative disease cases do represent genuine malignancy driven by unchecked viral infection.
Smoking is another chronic irritant that modestly raises lymphocyte counts over time. If you are a smoker with mildly elevated lymphocytes and no other concerning features, your doctor may factor in smoking as a contributing cause before pursuing an aggressive workup. The effect is well-documented but not dramatic, and it would not typically produce the kind of strikingly abnormal cells seen in infection or cancer.
What Happens If Your Doctor Finds Abnormal Lymphocytes
If you are reading this because your blood work came back with a flag for atypical or abnormal lymphocytes, the most useful thing to know is that context is everything. Your doctor will consider the whole picture: whether you have been sick recently, what medications you take, whether your other blood counts are normal, and whether the abnormal lymphocytes are a new finding or have been present on previous tests. A young person with a sore throat and fatigue who shows reactive lymphocytes is a completely different clinical situation from an older adult with persistently elevated lymphocytes and no symptoms.
In many cases, the next step is simply repeating the blood count in a few weeks to see if the abnormality resolves. If it does, no further workup is needed. If it persists, flow cytometry and possibly additional specialized testing follow. The progression from “something looks unusual” to “we have a specific diagnosis” can involve several steps and take weeks, which is frustrating but reflects the reality that distinguishing reactive from malignant lymphocytes requires more information than a single blood draw can provide.